Health inequities persist, impacting diverse populations and creating significant challenges. The TAG Digital Health Signature event highlights the pressing disparities in children's health, women's health, and rural health including solutions to address them.
Children experience health disparities due to limited access to pediatric care and preventive services, often due to factors such as poorer socioeconomic situation and ethnicity that lead to worse health outcomes.
Women experience health disparities due to inherent gender biases across the continuum from clinical research to practice of medicine. These disparities, exacerbated by factors such as socioeconomic status, ethnicity and culture, result in overall poorer health.
People living in rural geographies experience health disparities due to limited access to healthcare facilities and specialists resulting in delayed care and poorer outcomes for rural populations.
Addressing these inequities requires innovative solutions and a commitment to advancing health equity. The TAG Digital Health Signature Event will explore these issues, focusing on actionable strategies to bridge gaps and ensure a more equitable healthcare future for all.
Join us for a panel on each of these topics, a keynote, networking and a showcase of companies working to address these issues. (If your company focuses on one or more of these areas and is interested in being featured in the showcase, select Yes during registration. If you qualify, the cost is nominal - just $200 per company which includes 2 tickets and a small table in the networking area.)
Join us for presentations and discussion around future research opportunities and how GTRI applied technology capabilities can work with RI's basic science to explore forward-looking opportunities for GT.
We invite you to join us on December 12 at 5:00 PM in the HSRB 1 Café for the December 2024 Child Health Research Beer Core Networking Event! Enjoy a casual evening of beer, pizza, and great conversation as we gear up for the holiday season. This event also marks a special occasion: we’ll be warmly welcoming Dr. Shari Barkin, MD, MSHS, our new Department of Pediatrics Chair (Emory University) and Pediatrician-in-Chief (Children's Healthcare of Atlanta).
Sumedh Bele, PhD, MBBS, MPH
Banting Postdoctoral Research Fellow
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences
Medical Sciences Division
University of Oxford
United Kingdom
Adjunct Lecturer
Precision Health Program
Cumming School of Medicine
University of Calgary
Canada
Transforming Child Mental Health Services: Harnessing Patient-Reported Outcomes to Improve Mental Health and Innovate Healthcare Delivery
Please register by January 17th to secure a lunch.
Anita Villani is a Staff Oncologist at The Hospital for Sick Children and an Associate Professor in the Department of Paediatrics at the University of Toronto. She has a clinical and research interest in cancer genetics and predisposition, and in the translational implementation of genomic sequencing technologies into clinical oncology care. Anita is the Co-Director of the SickKids Precision Oncology Research Program (“KiCS”) and an active member of the Canadian national precision medicine program, PROFYLE. She is co-Principle Investigator of the Consortium for Childhood Cancer Predisposition (C3P) and of a multicentre, longitudinal registry study, the Childhood Cancer Predisposition Study (CCPS). She is co-chair of the Pediatric Cancer Predisposition Working Group within the Children’s Oncology Group (COG).
Anita received her medical degree at the University of Ottawa. She completed both her Paediatric residency training and Haematology/Oncology fellowship at The Hospital for Sick Children in Toronto. She obtained her Master of Science degree in Genetics and Genome Biology through the Clinician Investigator Program and Institute of Medical Science at the University of Toronto.
Dr Villani will present her seminar entitled "Risk of Therapy-Related Subsequent Cancers in Individuals with Li-Fraumeni Syndrome: An Example of Collaboration to Advance Care and Research for Childhood Cancer Predispositions"
Join us for the Georgia Tech Pediatric Innovation Network Invited Speaker Series, featuring Kristen Mittal, MS, RAC, PMP, Founder and CEO of Mittal Consulting. In her talk, "Decoding FDA Regulations: Pitfalls and Pearls for Medtech Entrepreneurs," Kristen will share her extensive expertise in regulatory affairs for Class I, II, and III medical devices. Learn key strategies to navigate FDA regulations, avoid common pitfalls, and set your medtech venture up for success. This session is perfect for entrepreneurs, innovators, and healthcare professionals eager to excel in the medical device industry.
Emerging evidence has highlighted that protein intrinsic disorder is a prominent feature in the proteomes of living systems. Such disordered protein structures represent a frontier for new discoveries in protein science. With the advent of new tools in AI and machine learning, and a growing realization of the connection between protein disorder, dynamic protein modification, protein folding, and molecular assemblies (e.g. amyloids or phase-separated protein structures), the field has seen considerable growth in recent years and shares the promise of new discoveries in protein design, control, and fundamental biological understanding. This symposium will host five internationally recognized external speakers and five Georgia Tech faculty with research foci in three major areas of interest, including: LLPS/Molecular Compartmentalization, Disorder/Order Transitions, and Protein Misfolding/Amyloids.
Join us for an enlightening episode of the Pediatric Tech Talk Webinar featuring Dr. Gabriel Kwong, a pioneering expert in bioengineering and immunology. Dr. Kwong, an Associate Professor at Georgia Tech and Emory University, will discuss cutting-edge advancements in immune cell engineering and biosensors that are transforming pediatric healthcare. Discover how these innovations enhance cancer treatment precision and expand access to life-saving therapies. Whether you're a specialist or a science enthusiast, this session offers valuable insights into the future of biomedical technology. Don’t miss this opportunity to learn from a leader in the field!
The Tech AI Fest 2025 hosted by Tech AI at Georgia Tech, will take place March 26–28 at the Historic Academy of Medicine. This event will showcase AI innovation, networking, and collaboration through talks, panels, and presentations featuring leaders from academia, government, and industry, along with researchers, students, and alumni.
Tech AI is dedicated to advancing artificial intelligence research and field deployment through innovation, collaboration, industry partnerships and workforce development. Its mission is to create an empowering platform for AI researchers at Georgia Tech to transform scientific breakthroughs into societal impacts.
A company’s regulatory strategy can determine its success—or failure. For investors, venture capital professionals, and family office managers, understanding the key regulatory milestones in the life sciences sector is essential to assessing risk, managing timelines, and making informed investment decisions.
This virtual session will provide a deep dive into the FDA regulatory process for medical devices and life science innovations, helping you identify red flags, evaluate a company’s regulatory preparedness, and ask the right questions before investing.
What You’ll Gain:
A structured overview of regulatory pathways for medical devices, diagnostics, and combination products.
Insights into how regulatory readiness impacts valuation, funding strategies, and market entry.
Key risk factors that can delay approval and increase costs.
Practical guidance on evaluating regulatory due diligence and company readiness.
Who Should Attend:
This session is designed for investors, venture capital professionals, entrepreneurs, and family office managers seeking to strengthen their understanding of the regulatory landscape in life sciences.